XML 15 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
CURRENT ASSETS    
Cash and cash equivalents $ 65,269 $ 73,256
Short-term investments 205,719 102,556
Accounts receivable 0 27,000
Prepaid expenses and other current assets 6,128 5,110
Total current assets 277,116 207,922
Property and equipment, net 15,378 14,449
Operating lease right of use assets 28,105  
Restricted cash 730 730
Other non-current assets 3,146 3,247
TOTAL ASSETS 324,475 226,348
CURRENT LIABILITIES    
Accounts payable 4,486 8,434
Accruals and other current liabilities 13,521 14,948
Deferred revenue, current portion 13,054 8,588
Operating lease liabilities, current portion 3,009  
Total current liabilities 34,070 31,970
Derivative liability associated with the Medicis settlement 2,845 2,753
Deferred revenue, net of current portion 37,940 42,684
Operating lease liabilities, net of current portion 28,517  
Deferred rent 0 3,319
TOTAL LIABILITIES 103,372 80,726
Commitments and Contingencies (Note 7)  
STOCKHOLDERS’ EQUITY    
Convertible preferred stock, par value $0.001 per share — 5,000,000 shares authorized, and no shares issued and outstanding as of March 31, 2019 and December 31, 2018 0 0
Common stock, par value $0.001 per share — 95,000,000 shares authorized as of March 31, 2019 and December 31, 2018; 44,004,658 and 36,975,203 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively 44 37
Additional paid-in capital 941,068 830,368
Accumulated other comprehensive income (loss) 70 (8)
Accumulated deficit (720,079) (684,775)
TOTAL STOCKHOLDERS’ EQUITY 221,103 145,622
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 324,475 $ 226,348